Novel Neuroprotective Treatment Option for Neonatal Hypoxic Ischemic Brain Injury
Neonatal hypoxia-ischemia (HI) remains a major global cause of neonatal morbidity and mortality. To develop effective therapeutic strategies, a deeper understanding of the acute inflammatory processes following HI is required.